Global Entyvio (vedolizumab) Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 12-Sep-2018
No. of pages: 107

Vedolizumab is a monoclonal antibody medicine developed by Takeda Pharmaceuticals for the treatment of ulcerative colitis and Crohn's disease.

Scope of the Report:

This report focuses on the Entyvio (vedolizumab) Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Entyvio (vedolizumab) Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Takeda

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Type 1

- Type 2

Market Segment by Applications, can be divided into

- Ulcerative Colitis

- Crohn's Disease

There are 15 Chapters to deeply display the global Entyvio (vedolizumab) Drug market.

Chapter 1, to describe Entyvio (vedolizumab) Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Entyvio (vedolizumab) Drug, with sales, revenue, and price of Entyvio (vedolizumab) Drug, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Entyvio (vedolizumab) Drug, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Entyvio (vedolizumab) Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Entyvio (vedolizumab) Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Entyvio (vedolizumab) Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents
1 Market Overview
1.1 Entyvio (vedolizumab) Drug Introduction
1.2 Market Analysis by Type
1.2.1 Type 1
1.2.2 Type 2
1.3 Market Analysis by Applications
1.3.1 Ulcerative Colitis
1.3.2 Crohn's Disease
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Takeda
2.1.1 Business Overview
2.1.2 Entyvio (vedolizumab) Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Takeda Entyvio (vedolizumab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Entyvio (vedolizumab) Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Entyvio (vedolizumab) Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Entyvio (vedolizumab) Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Entyvio (vedolizumab) Drug Manufacturer Market Share in 2017
3.3.2 Top 6 Entyvio (vedolizumab) Drug Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Entyvio (vedolizumab) Drug Market Analysis by Regions
4.1 Global Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Entyvio (vedolizumab) Drug Sales and Market Share by Regions (2013-2018)
4.1.2 Global Entyvio (vedolizumab) Drug Revenue and Market Share by Regions (2013-2018)
4.2 North America Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
4.3 Europe Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
4.5 South America Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
5 North America Entyvio (vedolizumab) Drug by Countries
5.1 North America Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Entyvio (vedolizumab) Drug Sales and Market Share by Countries (2013-2018)
5.1.2 North America Entyvio (vedolizumab) Drug Revenue and Market Share by Countries (2013-2018)
5.2 United States Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
5.3 Canada Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
5.4 Mexico Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
6 Europe Entyvio (vedolizumab) Drug by Countries
6.1 Europe Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Entyvio (vedolizumab) Drug Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Entyvio (vedolizumab) Drug Revenue and Market Share by Countries (2013-2018)
6.2 Germany Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
6.3 UK Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
6.4 France Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
6.5 Russia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
6.6 Italy Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
7 Asia-Pacific Entyvio (vedolizumab) Drug by Countries
7.1 Asia-Pacific Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Entyvio (vedolizumab) Drug Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Entyvio (vedolizumab) Drug Revenue and Market Share by Countries (2013-2018)
7.2 China Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
7.3 Japan Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
7.4 Korea Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
7.5 India Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
8 South America Entyvio (vedolizumab) Drug by Countries
8.1 South America Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Entyvio (vedolizumab) Drug Sales and Market Share by Countries (2013-2018)
8.1.2 South America Entyvio (vedolizumab) Drug Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
8.3 Argentina Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
8.4 Colombia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
9 Middle East and Africa Entyvio (vedolizumab) Drug by Countries
9.1 Middle East and Africa Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Entyvio (vedolizumab) Drug Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Entyvio (vedolizumab) Drug Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
9.3 UAE Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
9.4 Egypt Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
9.5 Nigeria Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
9.6 South Africa Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
10 Global Entyvio (vedolizumab) Drug Market Segment by Type
10.1 Global Entyvio (vedolizumab) Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Entyvio (vedolizumab) Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Entyvio (vedolizumab) Drug Revenue and Market Share by Type (2013-2018)
10.2 Type 1 Sales Growth and Price
10.2.1 Global Type 1 Sales Growth (2013-2018)
10.2.2 Global Type 1 Price (2013-2018)
10.3 Type 2 Sales Growth and Price
10.3.1 Global Type 2 Sales Growth (2013-2018)
10.3.2 Global Type 2 Price (2013-2018)
11 Global Entyvio (vedolizumab) Drug Market Segment by Application
11.1 Global Entyvio (vedolizumab) Drug Sales Market Share by Application (2013-2018)
11.2 Ulcerative Colitis Sales Growth (2013-2018)
11.3 Crohn's Disease Sales Growth (2013-2018)
12 Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
12.1 Global Entyvio (vedolizumab) Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Entyvio (vedolizumab) Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
12.2.2 Europe Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
12.2.4 South America Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
12.3 Entyvio (vedolizumab) Drug Market Forecast by Type (2018-2023)
12.3.1 Global Entyvio (vedolizumab) Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Entyvio (vedolizumab) Drug Market Share Forecast by Type (2018-2023)
12.4 Entyvio (vedolizumab) Drug Market Forecast by Application (2018-2023)
12.4.1 Global Entyvio (vedolizumab) Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Entyvio (vedolizumab) Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Entyvio (vedolizumab) Drug Picture
Table Product Specifications of Entyvio (vedolizumab) Drug
Figure Global Sales Market Share of Entyvio (vedolizumab) Drug by Types in 2017
Table Entyvio (vedolizumab) Drug Types for Major Manufacturers
Figure Type 1 Picture
Figure Type 2 Picture
Figure Entyvio (vedolizumab) Drug Sales Market Share by Applications in 2017
Figure Ulcerative Colitis Picture
Figure Crohn's Disease Picture
Figure United States Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure France Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure UK Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure China Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure India Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Entyvio (vedolizumab) Drug Revenue (Value) and Growth Rate (2013-2023)
Table Takeda Basic Information, Manufacturing Base and Competitors
Table Takeda Entyvio (vedolizumab) Drug Type and Applications
Table Takeda Entyvio (vedolizumab) Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Entyvio (vedolizumab) Drug Sales by Manufacturer (2016-2017)
Figure Global Entyvio (vedolizumab) Drug Sales Market Share by Manufacturer in 2016
Figure Global Entyvio (vedolizumab) Drug Sales Market Share by Manufacturer in 2017
Table Global Entyvio (vedolizumab) Drug Revenue by Manufacturer (2016-2017)
Figure Global Entyvio (vedolizumab) Drug Revenue Market Share by Manufacturer in 2016
Figure Global Entyvio (vedolizumab) Drug Revenue Market Share by Manufacturer in 2017
Figure Top 3 Entyvio (vedolizumab) Drug Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Entyvio (vedolizumab) Drug Manufacturer (Revenue) Market Share in 2017
Figure Global Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Global Entyvio (vedolizumab) Drug Revenue and Growth Rate (2013-2018)
Table Global Entyvio (vedolizumab) Drug Sales by Regions (2013-2018)
Table Global Entyvio (vedolizumab) Drug Sales Market Share by Regions (2013-2018)
Table Global Entyvio (vedolizumab) Drug Revenue by Regions (2013-2018)
Figure Global Entyvio (vedolizumab) Drug Revenue Market Share by Regions in 2013
Figure Global Entyvio (vedolizumab) Drug Revenue Market Share by Regions in 2017
Figure North America Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Europe Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure South America Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure North America Entyvio (vedolizumab) Drug Revenue and Growth Rate (2013-2018)
Table North America Entyvio (vedolizumab) Drug Sales by Countries (2013-2018)
Table North America Entyvio (vedolizumab) Drug Sales Market Share by Countries (2013-2018)
Figure North America Entyvio (vedolizumab) Drug Sales Market Share by Countries in 2013
Figure North America Entyvio (vedolizumab) Drug Sales Market Share by Countries in 2017
Table North America Entyvio (vedolizumab) Drug Revenue by Countries (2013-2018)
Table North America Entyvio (vedolizumab) Drug Revenue Market Share by Countries (2013-2018)
Figure North America Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2013
Figure North America Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2017
Figure United States Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Canada Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Mexico Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Europe Entyvio (vedolizumab) Drug Revenue and Growth Rate (2013-2018)
Table Europe Entyvio (vedolizumab) Drug Sales by Countries (2013-2018)
Table Europe Entyvio (vedolizumab) Drug Sales Market Share by Countries (2013-2018)
Table Europe Entyvio (vedolizumab) Drug Revenue by Countries (2013-2018)
Figure Europe Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2016
Figure Europe Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2017
Figure Germany Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure UK Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure France Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Russia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Italy Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Entyvio (vedolizumab) Drug Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Entyvio (vedolizumab) Drug Sales by Countries (2013-2018)
Table Asia-Pacific Entyvio (vedolizumab) Drug Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Entyvio (vedolizumab) Drug Sales Market Share by Countries 2017
Table Asia-Pacific Entyvio (vedolizumab) Drug Revenue by Countries (2013-2018)
Figure Asia-Pacific Entyvio (vedolizumab) Drug Revenue Market Share by Countries 2017
Figure China Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Japan Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Korea Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure India Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Southeast Asia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure South America Entyvio (vedolizumab) Drug Revenue and Growth Rate (2013-2018)
Table South America Entyvio (vedolizumab) Drug Sales by Countries (2013-2018)
Table South America Entyvio (vedolizumab) Drug Sales Market Share by Countries (2013-2018)
Figure South America Entyvio (vedolizumab) Drug Sales Market Share by Countries in 2017
Table South America Entyvio (vedolizumab) Drug Revenue by Countries (2013-2018)
Table South America Entyvio (vedolizumab) Drug Revenue Market Share by Countries (2013-2018)
Figure South America Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2017
Figure Brazil Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Argentina Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Colombia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Entyvio (vedolizumab) Drug Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Entyvio (vedolizumab) Drug Sales by Countries (2013-2018)
Table Middle East and Africa Entyvio (vedolizumab) Drug Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Entyvio (vedolizumab) Drug Sales Market Share by Countries in 2017
Table Middle East and Africa Entyvio (vedolizumab) Drug Revenue by Countries (2013-2018)
Table Middle East and Africa Entyvio (vedolizumab) Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2013
Figure Middle East and Africa Entyvio (vedolizumab) Drug Revenue Market Share by Countries in 2017
Figure Saudi Arabia Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure UAE Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Egypt Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure Nigeria Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Figure South Africa Entyvio (vedolizumab) Drug Sales and Growth Rate (2013-2018)
Table Global Entyvio (vedolizumab) Drug Sales by Type (2013-2018)
Table Global Entyvio (vedolizumab) Drug Sales Share by Type (2013-2018)
Table Global Entyvio (vedolizumab) Drug Revenue by Type (2013-2018)
Table Global Entyvio (vedolizumab) Drug Revenue Share by Type (2013-2018)
Figure Global Type 1 Sales Growth (2013-2018)
Figure Global Type 1 Price (2013-2018)
Figure Global Type 2 Sales Growth (2013-2018)
Figure Global Type 2 Price (2013-2018)
Table Global Entyvio (vedolizumab) Drug Sales by Application (2013-2018)
Table Global Entyvio (vedolizumab) Drug Sales Share by Application (2013-2018)
Figure Global Crohn's Disease Sales Growth (2013-2018)
Figure Global Entyvio (vedolizumab) Drug Sales, Revenue and Growth Rate (2018-2023)
Table Global Entyvio (vedolizumab) Drug Sales Forecast by Regions (2018-2023)
Table Global Entyvio (vedolizumab) Drug Market Share Forecast by Regions (2018-2023)
Figure North America Sales Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
Figure Europe Sales Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
Figure Asia-Pacific Sales Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
Figure South America Sales Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
Figure Middle East and Africa Sales Entyvio (vedolizumab) Drug Market Forecast (2018-2023)
Table Global Entyvio (vedolizumab) Drug Sales Forecast by Type (2018-2023)
Table Global Entyvio (vedolizumab) Drug Market Share Forecast by Type (2018-2023)
Table Global Entyvio (vedolizumab) Drug Sales Forecast by Application (2018-2023)
Table Global Entyvio (vedolizumab) Drug Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global Forearm Crutches Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 117
    A forearm crutch (also commonly known as an elbow crutch) has a cuff at the top to go around the forearm. It is used by inserting the arm into a cuff and holding the grip. The cuff, typically made of plastic or metal, can be a half-circle or a full circle with a V-type opening in the front allowing the forearm to slip out in case of a fall. Scope of the Report: Forearm crutches are the dominant type used in Europe, whether for short or long term use. Outside of Europe forea......
  • Global Platform Crutches Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 105
    Crutches assist individuals with leg injuries or disabilities to stand and walk comfortably. They help transfer weight from the legs to the upper body. They offer safety, added strength, stability and support to the user. Scope of the Report: Platform crutches are less common and used by those with poor hand or grip strength due to arthritis, cerebral palsy, or other conditions. The forearm rests on a horizontal platform and is usually strapped in place with velcro-type str......
  • Global Underarm Crutches Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 124
    Crutches assist individuals with leg injuries or disabilities to stand and walk comfortably. They help transfer weight from the legs to the upper body. They offer safety, added strength, stability and support to the user. Scope of the Report: Underarm crutches or axillary crutches are used by placing the pad against the ribcage beneath the armpit and holding the grip, which is below and parallel to the pad. They are usually used to provide support for patients who have temp......
  • Global Rotator Cuff Arthropathy Repair Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 115
    Rotator cuff arthropathy is a condition that occurs when a patient has both shoulder arthritis and irreparable rotator cuff tear. This disease generally occurs among older individuals and causes intense shoulder pain and loss of its strength and mobility. Rotator cuff arthropathy can occur as the result of degenerative conditions of the rotator cuff & bone as well as after fractures, failed partial/total shoulder replacements, or rotator cuff surgery. Scope of the Report: T......
  • Global Pulse Oximeter Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 124
    Pulse oximetry is a noninvasive and painless test that measures your oxygen saturation level, or the oxygen levels in your blood. It can rapidly detect even small changes in how efficiently oxygen is being carried to the extremities furthest from the heart, including the legs and the arms. Scope of the Report: The worldwide market for Pulse Oximeter is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ ......
  • Global Brain Aneurysm Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 116
    A brain aneurysm (AN-yoo-riz-um) is a bulge or ballooning in a blood vessel in the brain. It often looks like a berry hanging on a stem.A brain aneurysm can leak or rupture, causing bleeding into the brain (hemorrhagic stroke). Most often a ruptured brain aneurysm occurs in the space between the brain and the thin tissues covering the brain. This type of hemorrhagic stroke is called a subarachnoid hemorrhage. Scope of the Report: The worldwide market for Brain Aneurysm is e......
  • Global Body Sensors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 121
    Body sensors and are small medical devices used for continuously monitoring temperature, pressure and other vital parameters of health. These sensors are incorporated with electrodes that sensor such parameters. Continuous monitoring helps a person to take preventive measures and avoid any further complications to his health. Scope of the Report: The worldwide market for Body Sensors is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx millio......
  • Global Blue Biotechnology Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 120
    Blue biotechnology is the application of molecular biological methods to marine and freshwater organisms. These organisms are used for purposes like increasing seafood supply and safety, controlling the reproduction of dangerous water-borne organisms, and developing new drugs. Scope of the Report: The worldwide market for Blue Biotechnology is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, ......
  • Global Blood Transfusion Diagnostics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 21-Nov-2018        Price: US 3480 Onwards        Pages: 137
    Intravenous transfer of blood or blood products is known as blood transfusion. Replacement of lost blood components can be done with the help of blood transfusion. Blood components like red blood cells, white blood cells, platelets, clotting factors and plasma are mostly transfused. These blood components are of great importance to laboratories and hospitals during an emergency or a critical case of large volume of blood loss. RBC transfusion is done when hemoglobin levels fall below 100g/L. Blo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs